| P2093 | author name string | K Konopka | |
| | N Düzgüneş | |
| | N Shine | |
| P2860 | cites work | Human Submandibular Saliva Aggregates HIV | Q56765983 |
| | HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor | Q22242268 |
| | Identification of a major co-receptor for primary isolates of HIV-1 | Q22251282 |
| | Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase | Q24298754 |
| | Effect of mutations in the V3 loop of HIV-1 gp120 on infectivity and susceptibility to proteolytic cleavage | Q28267428 |
| | Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells | Q28270680 |
| | Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro | Q28293679 |
| | HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 | Q29616094 |
| | In vitro inhibition of HIV-1 infectivity by human salivas | Q34134156 |
| | Managing anxiety and pain during dental treatment | Q36271203 |
| | T-cell membrane-associated serine protease, tryptase TL2, binds human immunodeficiency virus type 1 gp120 and cleaves the third-variable-domain loop of gp120. Neutralizing antibodies of human immunodeficiency virus type 1 inhibit cleavage of gp120. | Q38359834 |
| | Acutely infected Langerhans cells are more efficient than T cells in disseminating HIV type 1 to activated T cells following a short cell-cell contact | Q38885244 |
| | CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV–1 strains in a T–cell line | Q39326351 |
| | In defense of the oral cavity: structure, biosynthesis, and function of salivary mucins | Q40543262 |
| | Proteases and antiproteases in cystic fibrosis: pathogenetic considerations and therapeutic strategies | Q40551139 |
| | Epidermal and mucosal dendritic cells and HIV1 infection | Q40616919 |
| | HIV infection and the dentist. 1. The presence of HIV in saliva and its implications to dental practice | Q40664942 |
| | HIV infection and the dentist. 2. The diagnosis and management of gingivitis and periodontitis | Q40664948 |
| | Lymphoid changes of the nasopharyngeal and palatine tonsils that are indicative of human immunodeficiency virus infection. A clinicopathologic study of 12 cases | Q40669536 |
| | Strong ionic interactions between mucins and two basic proteins, mucus proteinase inhibitor and lysozyme, in human bronchial secretions | Q41142222 |
| | The beta-chemokines, HIV type 1 second receptors, and exposed uninfected persons | Q41166065 |
| | Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor | Q41221414 |
| | HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. | Q41223643 |
| | A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity | Q41362201 |
| | T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells | Q41508169 |
| | A human lymphoid recombinant cell line with functional human immunodeficiency virus type 1 envelope | Q41586283 |
| | Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro | Q41858067 |
| | Inhibition of U‐937 membrane‐associated cathepsin G by GP 120 (IIIB) and V3 loop‐derived peptides from several strains of HIV‐1 | Q42276973 |
| | Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV. | Q43696929 |
| | HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS. | Q44467380 |
| | Saliva inhibits HIV-1 infectivity | Q44480598 |
| | Mechanisms of sexual transmission of HIV: does HIV infect intact epithelia? | Q44755366 |
| | Infection of oral mucosal cells by human immunodeficiency virus type 1 in seropositive persons | Q44830736 |
| | Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis | Q45080577 |
| | Outpatient biopsies of the palatine tonsil: access to lymphoid tissue for assessment of human immunodeficiency virus RNA titers | Q45770564 |
| | Patients infected with human immunodeficiency virus type 1 have low levels of virus in saliva even in the presence of periodontal disease | Q45773735 |
| | In vitro infection of epidermal Langerhans cells with human immunodeficiency virus type 1 (HTLV-IIIB isolate). | Q45773780 |
| | Low occupational risk of human immunodeficiency virus infection among dental professionals | Q45831758 |
| | Components of saliva inactivate human immunodeficiency virus | Q45840053 |
| | Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection | Q45847307 |
| | Heparin-induced conformational change and activation of mucus proteinase inhibitor. | Q50790111 |
| | Tissue distribution of antileukoprotease and lysozyme in humans. | Q53678454 |
| | Tryptase TL2in the membrane of human T4+lymphocytes is a novel binding protein of the V3 domain of HIV-1 envelope glycoprotein gp120 | Q55241764 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | saliva | Q155925 |
| P304 | page(s) | 634-640 | |
| P577 | publication date | 1997-02-01 | |
| P1433 | published in | Journal of Dental Research | Q6295082 |
| P1476 | title | The anti-HIV-1 activity associated with saliva | |
| P478 | volume | 76 | |